These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29903413)

  • 21. In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase.
    Liu H; Yao X; Wang C; Han J
    Mol Pharm; 2010 Jun; 7(3):894-904. PubMed ID: 20420444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
    Xie Y; Xu D; Huang B; Ma X; Qi W; Shi F; Liu X; Zhang Y; Xu W
    J Med Chem; 2014 Oct; 57(20):8445-58. PubMed ID: 25255388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective Inhibitors of Human Neuraminidase 1 (NEU1).
    Guo T; Héon-Roberts R; Zou C; Zheng R; Pshezhetsky AV; Cairo CW
    J Med Chem; 2018 Dec; 61(24):11261-11279. PubMed ID: 30457869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular dynamics directed CoMFA studies on carbocyclic neuraminidase inhibitors.
    Chavan S; Bhayye S; Sobhia ME
    Mol Divers; 2011 Nov; 15(4):979-87. PubMed ID: 21922291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A surface plasmon resonance assay for measurement of neuraminidase inhibition, sensitivity of wild-type influenza neuraminidase and its H274Y mutant to the antiviral drugs zanamivir and oseltamivir.
    Somasundaram B; Fee CJ; Fredericks R; Watson AJ; Fairbanks AJ; Hall RJ
    J Mol Recognit; 2015 Sep; 28(9):521-7. PubMed ID: 25727669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insight into substrate recognition and catalysis by the human neuraminidase 3 (NEU3) through molecular modeling and site-directed mutagenesis.
    Albohy A; Li MD; Zheng RB; Zou C; Cairo CW
    Glycobiology; 2010 Sep; 20(9):1127-38. PubMed ID: 20511247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation analyses on binding affinity of sialic acid analogues and anti-influenza drugs with human neuraminidase using ab initio MO calculations on their complex structures--LERE-QSAR analysis (IV).
    Hitaoka S; Matoba H; Harada M; Yoshida T; Tsuji D; Hirokawa T; Itoh K; Chuman H
    J Chem Inf Model; 2011 Oct; 51(10):2706-16. PubMed ID: 21870866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Selective Nanomolar Inhibitors of the Human Neuraminidase, NEU4.
    Albohy A; Zhang Y; Smutova V; Pshezhetsky AV; Cairo CW
    ACS Med Chem Lett; 2013 Jun; 4(6):532-7. PubMed ID: 24900705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor.
    Wu Y; Gao F; Qi J; Bi Y; Fu L; Mohan S; Chen Y; Li X; Pinto BM; Vavricka CJ; Tien P; Gao GF
    J Virol; 2016 Dec; 90(23):10693-10700. PubMed ID: 27654293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based design and synthesis of C-1- and C-4-modified analogs of zanamivir as neuraminidase inhibitors.
    Feng E; Shin WJ; Zhu X; Li J; Ye D; Wang J; Zheng M; Zuo JP; No KT; Liu X; Zhu W; Tang W; Seong BL; Jiang H; Liu H
    J Med Chem; 2013 Feb; 56(3):671-84. PubMed ID: 23330908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
    Magano J
    Chem Rev; 2009 Sep; 109(9):4398-438. PubMed ID: 19537777
    [No Abstract]   [Full Text] [Related]  

  • 32. Selective Inhibitors of Human Neuraminidase 3.
    Guo T; Dätwyler P; Demina E; Richards MR; Ge P; Zou C; Zheng R; Fougerat A; Pshezhetsky AV; Ernst B; Cairo CW
    J Med Chem; 2018 Mar; 61(5):1990-2008. PubMed ID: 29425031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homology modeling, docking, and molecular dynamics reveal HR1039 as a potent inhibitor of 2009 A(H1N1) influenza neuraminidase.
    Wang YT; Chan CH; Su ZY; Chen CL
    Biophys Chem; 2010 Mar; 147(1-2):74-80. PubMed ID: 20045243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1.
    Meeprasert A; Khuntawee W; Kamlungsua K; Nunthaboot N; Rungrotmongkol T; Hannongbua S
    J Mol Graph Model; 2012 Sep; 38():148-54. PubMed ID: 23079644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioisosteres at C9 of 2-Deoxy-2,3-didehydro-
    Radwan M; Guo T; Carvajal EG; Bekkema BAR; Cairo CW
    J Med Chem; 2024 Aug; 67(16):13594-13603. PubMed ID: 39101748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.
    Neri-Bazán RM; García-Machorro J; Méndez-Luna D; Tolentino-López LE; Martínez-Ramos F; Padilla-Martínez II; Aguilar-Faisal L; Soriano-Ursúa MA; Trujillo-Ferrara JG; Fragoso-Vázquez MJ; Barrón BL; Correa-Basurto J
    Eur J Med Chem; 2017 Mar; 128():154-167. PubMed ID: 28182988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations at the monomer-monomer interface away from the active site of influenza B virus neuraminidase reduces susceptibility to neuraminidase inhibitor drugs.
    Fujisaki S; Imai M; Takashita E; Taniwaki T; Xu H; Kishida N; Yokoyama M; Sato H; Tashiro M; Odagiri T
    J Infect Chemother; 2013 Oct; 19(5):891-5. PubMed ID: 23529501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs.
    Dholakia D; Goyal S; Jamal S; Singh A; Das A; Grover A
    BMC Bioinformatics; 2016 Dec; 17(Suppl 19):512. PubMed ID: 28155702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Creation of a generalized model prediction of inhibition of neuraminidase of influenza virus of various strains].
    Mikurova AV; Skvortsov VS
    Biomed Khim; 2018 Jun; 64(3):247-252. PubMed ID: 29964260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody against Microbial Neuraminidases Recognizes Human Sialidase 3 (NEU3): the Neuraminidase/Sialidase Superfamily Revisited.
    Feng C; Li J; Snyder G; Huang W; Goldblum SE; Chen WH; Wang LX; McClane BA; Cross AS
    mBio; 2017 Jun; 8(3):. PubMed ID: 28655817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.